CVM-2024-121486-Establish-Preventative Maintenance Agreement (PMA), Base Year plus Two (2) option years, for Q-Exactive SN05491L   8

Background
The U. S. Food & Drug Administration, (FDA) Office of Acquisition and Grants Services (OAGS) has a requirement to procure a CVM-2024-121486 Establish-Preventative Maintenance Agreement (PMA), Base Year plus Two (2) option years, for Q-Exactive SN05491L under solicitation FDA-RFQ-CVM-2024.

Work Details
The contract involves the establishment of a Preventative Maintenance Agreement for a specific equipment, Q-Exactive SN05491L, with a base year and two option years. The Statement of Work (SOW) outlines technical directions to the Contractor, providing information for interpretation of specifications, and reviewing/approving technical reports and information. It also specifies the authority of the Technical Point of Contact (TPOC) and Contracting Officer (CO) in issuing technical directions and approving changes. Additionally, it incorporates various contract clauses by reference, including Basic Safeguarding of Covered Contractor Information Systems, Paperwork Reduction Act, Contractor Cooperation in Equal Employment Opportunity Investigations, Service Records and Reports, Certificate of Maintainability, and FDA Security and Privacy requirements.

Period of Performance
The period of performance includes the base year plus two option years for a total duration not exceeding 5 years.

Place of Performance
The geographic location(s) for the performance of the contract are not explicitly provided in the given information.